These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14402967)

  • 1. [Concentrations of PAS and INH in sputa of patients receiving them orally and the method for their inactivation. Report 1. Free PAS concentrations in sputum].
    HONJO S
    Kekkaku; 1960 Feb; 35():104-8. PubMed ID: 14402967
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of isoniazid and para-amino salicylic acid (PAS) in the organism and its therapeutic significance.
    BANG HO; JACOBSEN LK; STRANDGAARD E; YDE H
    Acta Tuberc Pneumol Scand; 1962; 41():237-51. PubMed ID: 13864641
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies with C14 labeled para-aminosalicylic acid and isoniazid.
    EBERT RH; HELLER A; KOCH-WESER D; ROTH LJ
    Am Rev Tuberc; 1957 Jan; 75(1):71-82. PubMed ID: 13394864
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the renal clearances, metabolic inactivation rates, and serum fall-off interaction of isoniazid and paraminosalicylic acid in man.
    JENNE JW; MACDONALD FM; MENDOZA E
    Am Rev Respir Dis; 1961 Sep; 84():371-8. PubMed ID: 13789848
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isonicotinic acid hydrazide, PAS and T-40 metabolism in the animal organism].
    JAKIMOWSKA K
    Postepy Biochem; 1958; 4(4):471-9. PubMed ID: 13623519
    [No Abstract]   [Full Text] [Related]  

  • 6. Concentrations of para-aminosalicylic acid (PAS) and isonicotinic acid hydrazide in sputum.
    SATO S; TAYAMA A
    Sci Rep Res Inst Tohoku Univ Med; 1955 Oct; 6(3):309-22. PubMed ID: 13298721
    [No Abstract]   [Full Text] [Related]  

  • 7. [Concentration and excretion of isoniazid and PAS in patients with tuberculosis depending on the functional status of the kidney].
    Savula MM; Kiselova ES
    Vrach Delo; 1978 May; (5):119-22. PubMed ID: 676253
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics of isoniazid, PAS, and cycloserin in acute and chronic alcoholic intoxication (experimental study)].
    Ortenberg ZA
    Probl Tuberk; 1978 Sep; (9):60-4. PubMed ID: 568263
    [No Abstract]   [Full Text] [Related]  

  • 9. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative studies on the behavior of PAS and isonicotinic acid hydrazide during gestation and lactation in the experimental animal].
    RENOVANZ HD; SCHATTMANN K
    Arztl Wochensch; 1953 Apr; 8(15):354-9. PubMed ID: 13065215
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the metabolism of isoniazid. 2. The influence of para-aminosalicylic acid on the metabolism of isoniazid by man.
    PETERS JH
    Am Rev Respir Dis; 1960 Aug; 82():153-63. PubMed ID: 13734775
    [No Abstract]   [Full Text] [Related]  

  • 12. SINGLE DAILY DOSE REGIMEN OF ISONIAZID AND PAS IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
    WILSON JL; LAMPE WT
    Am Rev Respir Dis; 1964 May; 89():756-9. PubMed ID: 14145228
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liver function and INH and PAS metabolism in tuberculous adolescents with side reactions to chemotherapy].
    Tytor IaN; Koropetskiĭ VI
    Vrach Delo; 1977 Jun; (6):61-4. PubMed ID: 883281
    [No Abstract]   [Full Text] [Related]  

  • 14. SPECTROPHOTOMETRIC INVESTIGATION OF ISONICOTINOYL HYDRAZIDE (INH). A CONTRIBUTION TO THE KNOWLEDGE OF THE YELLOW ISONICOTINOYL HYDRAZIDE RHO-AMINOSALICYLIC ACID COMBINATION (INH-PAS).
    REKKER RF; NAUTA WT
    Pharm Weekbl; 1964 Oct; 99():1157-65. PubMed ID: 14230284
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of the level of free isonicotinic acid hydrazine in the blood serum determined with a vertical method after the oral administration of INH alone, INH with PAS or Napashin].
    KOLOSOWSKA J; LIBISZOWSKA-STANIUL M
    Gruzlica (1926); 1962 Jan; 30():35-8. PubMed ID: 14458075
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acetylation phenotype and biotransformation of various drugs].
    Grygorowicz J; Januszko J
    Wiad Lek; 1987 Mar; 40(5):319-23. PubMed ID: 3303698
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of para-aminosalicylic acid (PAS), isoniazid (INH) and 2-ethylisothionicotinamide (TH1314) on the activity of the thyroid gland of the rat.
    SIMILA S; LAHTINEN K; MAKINEN E; NAATANEN E; RIEKKINEN P
    Acta Tuberc Pneumol Scand; 1962; 42():73-8. PubMed ID: 13913017
    [No Abstract]   [Full Text] [Related]  

  • 18. [STUDIES ON COMBINED INH-ETHIONAMIDE TREATMENT OF PULMONARY TUBERCULOSIS WITH LOW ETHIONAMIDE DOSAGE].
    DISSMANN E; IGLAUER E; ZECHNER E
    Tuberkulosearzt; 1963 Nov; 17():696-704. PubMed ID: 14098678
    [No Abstract]   [Full Text] [Related]  

  • 19. [CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)].
    LEHIR M; CHICOU J; HETRICK G; MERCIER A; NEEL R; RIST N
    Bull World Health Organ; 1964; 30(5):701-32. PubMed ID: 14196816
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of the absorption and tolerance of para-aminosalicylic acid administered in the form of a PAS-vitaminpectin complex].
    BROCARD H; BOUILLAC R; BERTHELOT J
    Therapie; 1952; 7(1):9-11. PubMed ID: 14950786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.